Onco-Innovations Limited (NEO:ONCO)

Market Cap	69.06M
Revenue (ttm)	154.67K
Net Income	-14.26M
EPS	-0.33
Shares Out	57.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	35,779
Open	1.100
Previous Close	1.250
Day's Range	1.100 - 1.100
52-Week Range	0.900 - 2.800
Beta	n/a
RSI	40.12
Earnings Date	Mar 17, 2026

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada.

• Industry: Biological Products, Except Diagnostic Substances
• CEO: Thomas O’Shaughnessy
• Country: Canada
• Stock Exchange: Cboe Canada
• Ticker Symbol: ONCO